NCT05218980

Brief Summary

The purpose of this study is to assess whether introducing table olives into the diet results in health-related benefits for young adults. Several studies have shown that addition of olives as part of somebody's diet has a positive impact on cardiovascular, metabolic, and inflammatory factors. However, there have not been many studies among young, healthy adults. This study will compare levels of specific biomarkers, collected through blood draw, at the beginning of the study and after 5 weeks, to evaluate the effects of investigational daily olive consumption.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
226

participants targeted

Target at P75+ for not_applicable

Timeline
1mo left

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Jan 2026Jun 2026

First Submitted

Initial submission to the registry

January 19, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 1, 2022

Completed
3.9 years until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

April 9, 2025

Status Verified

April 1, 2025

Enrollment Period

3 months

First QC Date

January 19, 2022

Last Update Submit

April 8, 2025

Conditions

Keywords

olives

Outcome Measures

Primary Outcomes (2)

  • Change From Baseline in Mean LDL at Week 5

    Blood draw to assess LDL at baseline and week five. Change will be calculated by comparing means of the differences (5 weeks-Baseline) between the two study groups, a decrease in the mean from baseline is positive.

    at baseline and week 5

  • Compliance/adherence to daily intervention

    Assessment and verification of receipt of the olives will be tied to the dining hall card swipe that is part of the student's access to the dining facility, for study participants in the olives group. Swipe=adherent.

    up to week 5

Secondary Outcomes (4)

  • Change From Baseline in Mean HDL at Week 5

    at baseline and week 5

  • Change From Baseline in Mean LDL/HDL at Week 5

    at baseline and week 5

  • Change From Baseline in Mean HbA1c at Week 5

    at baseline and week 5

  • Change From Baseline in Mean CRP at Week 5

    at baseline and week 5

Study Arms (2)

Investigational

EXPERIMENTAL

Yale Dining menu + 6 olives daily

Dietary Supplement: Olives

Standard

NO INTERVENTION

Yale Dining menu only

Interventions

OlivesDIETARY_SUPPLEMENT

Organic olives (provided by Sakellaropoulos Organic Farms; Sparta, Greece)

Investigational

Eligibility Criteria

Age18 Years - 23 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Yale College Freshman, Sophomore, or Junior
  • Ability and desire to sign informed consent
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, age 18 on the day of consent
  • Ability and desire to consume 6 olives daily

You may not qualify if:

  • Yale College Senior
  • Unable to provide informed consent form
  • Self-reported pregnancy
  • Unwillingness to comply with all study procedures and/or be available for the duration of the study
  • Inability and desire to consistently consume 6 olives per day
  • Inability to consume fruit with pits
  • Current and consistent use of \> 6 olives per day
  • Current and consistent use of ≥ 1 tablespoon of extra virgin olive oil (EVOO) per day
  • Known allergic reactions to olives and/or their derivatives
  • Known reactions to blood draw

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale University

New Haven, Connecticut, 06520, United States

Location

Study Officials

  • Tassos Kyriakides, PhD

    Yale University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tassos Kyriakides, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2022

First Posted

February 1, 2022

Study Start

January 1, 2026

Primary Completion

April 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

April 9, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in the primary publication; after deidentification (text, tables, figures and appendices)

Shared Documents
STUDY PROTOCOL
Time Frame
Beginning 12 months and ending 36 months following primary publication.
Access Criteria
Proposals should be directed to tassos.kyriakides@yale.edu. To gain access, data requestors will need to sign a data use access/use agreement and have approval from an institutional review board/ethics board for the proposed use of such data.

Locations